200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 4143-64-0

4143-64-0

4143-64-0 | 2-(3,4-Dihydroxyphenyl)-4H-chromen-4-one

CAS No: 4143-64-0 Catalog No: AG003IHR MDL No:MFCD00017600

Product Description

Catalog Number:
AG003IHR
Chemical Name:
2-(3,4-Dihydroxyphenyl)-4H-chromen-4-one
CAS Number:
4143-64-0
Molecular Formula:
C15H10O4
Molecular Weight:
254.2375
MDL Number:
MFCD00017600
IUPAC Name:
2-(3,4-dihydroxyphenyl)chromen-4-one
InChI:
InChI=1S/C15H10O4/c16-11-6-5-9(7-13(11)18)15-8-12(17)10-3-1-2-4-14(10)19-15/h1-8,16,18H
InChI Key:
SRNPMQHYWVKBAV-UHFFFAOYSA-N
SMILES:
Oc1ccc(cc1O)c1cc(=O)c2c(o1)cccc2
UNII:
KOH101S66V

Properties

Complexity:
390  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
254.058g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
254.241g/mol
Monoisotopic Mass:
254.058g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
66.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.8  

Literature

Title Journal
Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chemico-biological interactions 20151205
The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones. Biochemical pharmacology 20131215
Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin. Platelets 20130101
Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening. Journal of medicinal chemistry 20121011
3,3',4',5,5'-Pentahydroxyflavone is a potent inhibitor of amyloid β fibril formation. Neuroscience letters 20120328
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorganic & medicinal chemistry 20110501
Characterization of an O-methyltransferase from Streptomyces avermitilis MA-4680. Journal of microbiology and biotechnology 20100901
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists. Journal of medicinal chemistry 20091112
Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. Nutrition and cancer 20090101
Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton transactions (Cambridge, England : 2003) 20071121
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation. Bioorganic & medicinal chemistry letters 20070301
Evaluation of novel chromogenic substrates for the detection of bacterial beta-glucosidase. Journal of applied microbiology 20070201
The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes. Biological & pharmaceutical bulletin 20070101
Spectroscopic and theoretical studies of the Zn(II) chelation with hydroxyflavones. The journal of physical chemistry. A 20061116
Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity. Planta medica 20060601
Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. The Journal of biological chemistry 20050909
Time dependent density functional theory study of electronic absorption properties of lead(II) complexes with a series of hydroxyflavones. The journal of physical chemistry. A 20050804
Stability of ferric complexes with 3-hydroxyflavone (flavonol), 5,7-dihydroxyflavone (chrysin), and 3',4'-dihydroxyflavone. Journal of agricultural and food chemistry 20050420
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochemical pharmacology 20050215
Catecholic flavonoids acting as telomerase inhibitors. Journal of medicinal chemistry 20041216
3',4'-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. British journal of pharmacology 20040601
The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent. Chemical research in toxicology 20020301
Complexes of Al(III) with 3'4'-dihydroxy-flavone: characterization, theoretical and spectroscopic study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20010301

© 2019 Angene International Limited. All rights Reserved.